Masimo (NASDAQ: MASI) announced today that O3® Regional Oximetry has received FDA clearance for use on neonatal indication and infant patients (<10 kg). O3...
Tag - masimo open connect
Press Releases
Research Papers
Events Calendar
Events
-
MEDICA 20252025-11-17 - 2025-11-20 -
FALL 2025 Innovators Summit2025-12-02 - 2025-12-04 -













